Diagnostic Biochips, Inc. (“DBC” or “Company”) is a Maryland-based biosensor platform technology firm that is redefining measurement in medicine. The Company has developed a proprietary sensor ‘functionalization’ process and a suite of biosensors that are set to transform the medical monitoring process. Its paradigm-shifting sensors are a cost-effective method for the direct and continuous monitoring of medically important chemicals.